Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GF-001001-00 cream in secondarily-infected traumatic skin lesions (Phase II)
2008-007055-28Phase 2Completed
- Sponsor
- Ferrer
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ozenoxacin in Not applicable and cutaneous lesion (4 arms), sponsored by Ferrer. Started Apr 2009; status: completed.
02
Drugs
ozenoxacin
03
Conditions
Not applicablecutaneous lesion
Beyond the preview
Go deeper on 2008-007055-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007055-28.